Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-01-31
2006-01-31
Hartley, Michael (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S465000, C514S225200, C514S568000, C514S557000
Reexamination Certificate
active
06991806
ABSTRACT:
A stable pharmaceutical composition comprising a mixture of (i) an ibuprofen medicament; (ii) a domperidone medicament and (iii) a carrier material characterized in that the carrier material is substantially free of providone and comprises at least one diluent combined with at least one release modifying agent.
REFERENCES:
patent: 3160562 (1964-12-01), Cerletti et al.
patent: 4983621 (1991-01-01), Bunce et al.
patent: 4985459 (1991-01-01), Sunshine et al.
patent: 5053429 (1991-10-01), Hirsch et al.
patent: 5215758 (1993-06-01), Krishnamurthy
patent: 5273759 (1993-12-01), Simmons
patent: 5460828 (1995-10-01), Santus et al.
patent: 5587179 (1996-12-01), Gergely et al.
patent: 5814339 (1998-09-01), Prudhoe
patent: 5891885 (1999-04-01), Caruso
patent: 5985874 (1999-11-01), Owen et al.
patent: 6319514 (2001-11-01), On
patent: 2020 018 (1991-12-01), None
patent: 0 327 040 (1989-08-01), None
patent: 2 313 309 (1997-11-01), None
patent: 95/22974 (1995-08-01), None
patent: 98/34612 (1998-08-01), None
patent: 00/21534 (2000-04-01), None
Postgraduate Medical Journal; “Headache”, Ruth Atkinson, M.D. and Otto Appenzeller, M.D., Ph.D., 60:841-846, (Dec. 1984).
J. Clin Pharmacol, Therapeutic Review, “Current Concepts of Migraine Therapy”, Seymour Diamond, M.D. and Ellen Millstein, M.D., 28:193-199, (1988).
The Medical Letter, On Drugs and Therapeutics; “Drugs for Migraine”, vol. 26, Issue 673, pp. 95-96 (Oct. 26, 1984).
Br Med. J, “Treating Migraine”, C. Clough, vol. 299, pp. 141-142 (Jul. 15, 1989).
Practical Therapeutics, “Migraine, Current Concepts of Pathogenesis and Treatment”, Richard Peatfield, Drugs 26:364-371, (1983).
Br. Med. J, “Sumatriptan in Migraine”, JMS Pearce, vol. 303 (Dec. 14, 1991).
The Annals of Pharmacotherapy, “Sumatriptan: A Selective 5-Hydroxytryptamine Receptor Agonist For The Acute Treatment of Migraine”, Terence Fullerton and Fran M. Gengo, vol. 26, pp. 800-808, (1992).
Eur N urol, “A Study to Compare Oral Sumatriptan with Oral Aspirin plus Oral Metoclopramide in the Acute Treatment of Migraine”, Ms. C.J. Thomson, Study Coordinator, 32:177-184 (1992).
Cephalalgia, “Domperidone Plus Paracetamol in the Treatment of Migraine”, E. Anne MacGregor, et al., 13(2):124-127 (1993).
Therapia. Hungarica, “The Role of a Peripheral Dopamine-Antagonist(Motilium)in Improving the Tolerance to Steroidal and Non-Steroidal Anti-Inflammatory Agents”, Z. Zahumenszky, et al., vol. 38, pp. 156-159 (1990).
Postgrad. Med. J. Suppl., “The Effect of Domperidone on the Gastric Tolerance and Efficacy of Non-Steroidal Anti-Inflammatory Drugs on Osteo-Arthritis”, L. Depuydt et al., vol. 55, No. 1, p. 52 (1979).
The Pharmaceutical Journal, “Migraine-Separate Administration of Antiemetic and Analgesic Drugs Recommended”, p. 654, (Nov. 26, 1983).
Deutsche Apotheker Zeltung, “Selbstmedikation bei Migraene and Kopfschmerz vom Spannugstyp”, H. Goebelvol. et al., 135, No. 9, (Mar. 2, 1995).
Nuova Rivista di Neurologia, “Linee-guida per II Trattamento Dell'attacco Acuto”, Franco Granella, Suppl. al vol. 5, No. 6 (Dec. 1995).
Meunch. Med. Wahr, “Therapie des Medikamenteninduzierten Dauerkopfschmerzes”, H.C. Diener et al., vol. 134, No. 10, pp. 159-162 (1992).
Abstract of Schmerz, “Medical Therapy for Menstrual Migraine”, V. Pfaffenrath et al., vol. 10, No. 3, pp. 146-148 (1996).
Adstract of Acta. Clin., “Pharmacology of Migraine”, V. Demarin et al., vol. 32, No. 2, pp. 81-89 (1995).
Abstract of Internist, “Pain Therapy in Chronic Headache and Migraine”, H.C. Diener, vol. 35, No. 1, pp. 26-31 (1994).
Abstract of Pain, “Behavioural and Prophylactic Pharmacological Intervention Studies of Pediatric Migraine: An Exploatory Meta-analysis”, C. Hermann et al., vol. 60, No. 3, pp. 329-356 (1995).
Abstract of Cephalagia, “Analgesics and NSAIDs in the Treatment of the Acute Migraine Attack”, V. Pfaffenrath et al., Suppl. 15, vol. 15, pp. 14-20 (1995).
Abstract of Eur-Neurol., “A Review of Current Treatments for Migraine”, H.C. Diener, Suppl. 2, vol. 34, pp. 18-25 (1994).
Abstract of Scott Med J., “Migraine—Treatment of Acute Attack”, V. Pfaffenrath et al., vol. 138, No. 23-24, pp 591-599 (1988).
Abstract of Scott Med J., “Migraine—Treatment of Acute Attack”, M. Wilkinson, vol. 30, No. 4, pp 258-262 (1985).
Abstract of Cephalagia, “Treatment of the Acute Migraine Attack—Current Status”, vol. 3, No. 1, pp 61-67 (1983).
Oesterr inhische Aetrzezeitung, “Migraene-Therapie”, D. Klingler et al., vol. 49, No. 24, pp. 26-30 (1994).
Antimigraine Drugs, Tim Steiner, PhD, LLM, MB, BS, MFPM,When and How To Use Antimigraine Drugs, pp. 45-58, Prescriber, Apr. 5, 1995.
Goodman & Gilman's The Pharmacological of Basis of Therapeutics, Paul A. Insel,Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout, (1996).
Dickinson Jeffrey
Makwana Jayantilal Vithal
Hartley Michael
Rothwell Figg Ernst & Manbeck P.C.
The Boots Company PLC
LandOfFree
Pharmaceutical compositions comprising ibuprofen and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising ibuprofen and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising ibuprofen and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581976